Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1980 2
1981 1
1988 1
1994 1
2000 1
2005 2
2006 1
2007 3
2008 1
2009 2
2010 1
2011 1
2013 2
2015 2
2017 2
2018 4
2019 4
2020 6
2021 5
2022 3
2023 7
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Immunological causes of obsessive-compulsive disorder: is it time for the concept of an "autoimmune OCD" subtype?
Endres D, Pollak TA, Bechter K, Denzel D, Pitsch K, Nickel K, Runge K, Pankratz B, Klatzmann D, Tamouza R, Mallet L, Leboyer M, Prüss H, Voderholzer U, Cunningham JL; ECNP Network Immuno-NeuroPsychiatry; Domschke K, Tebartz van Elst L, Schiele MA. Endres D, et al. Transl Psychiatry. 2022 Jan 10;12(1):5. doi: 10.1038/s41398-021-01700-4. Transl Psychiatry. 2022. PMID: 35013105 Free PMC article. Review.
Autoimmune encephalitis and systemic autoimmune diseases or other autoimmune brain diseases, such as multiple sclerosis, have also been reported to sometimes present with obsessive-compulsive symptoms (OCS). ...Red flag signs for "autoimmune OCD" could include (sub) …
Autoimmune encephalitis and systemic autoimmune diseases or other autoimmune brain diseases, such as multiple sclerosis, have …
Streptococcus thermophilus ST285 Alters Pro-Inflammatory to Anti-Inflammatory Cytokine Secretion against Multiple Sclerosis Peptide in Mice.
Dargahi N, Matsoukas J, Apostolopoulos V. Dargahi N, et al. Brain Sci. 2020 Feb 23;10(2):126. doi: 10.3390/brainsci10020126. Brain Sci. 2020. PMID: 32102262 Free PMC article.
As such, in the current study, we determined the effects of Streptococcus thermophilus to agonist MBP(83)(-)(99) peptide immunized mouse spleen cells. It was noted that Streptococcus thermophilus induced a significant increase in the expression of anti-inflammatory …
As such, in the current study, we determined the effects of Streptococcus thermophilus to agonist MBP(83)(-)(99) peptide immunized mo …
Vaccination of multiple sclerosis patients during the COVID-19 era: Novel insights into vaccine safety and immunogenicity.
Kim E, Haag A, Nguyen J, Kesselman MM, Demory Beckler M. Kim E, et al. Mult Scler Relat Disord. 2022 Nov;67:104172. doi: 10.1016/j.msard.2022.104172. Epub 2022 Sep 10. Mult Scler Relat Disord. 2022. PMID: 36116380 Free PMC article. Review.
Multiple sclerosis (MS) is an incurable autoimmune disease known to cause widespread demyelinating lesions in the central nervous system (CNS) and a host of debilitating symptoms in patients. ...Discussed in this review are vaccinations against influenza, yellow fev …
Multiple sclerosis (MS) is an incurable autoimmune disease known to cause widespread demyelinating lesions in the central nerv …
Investigation of probiotics in multiple sclerosis.
Tankou SK, Regev K, Healy BC, Cox LM, Tjon E, Kivisakk P, Vanande IP, Cook S, Gandhi R, Glanz B, Stankiewicz J, Weiner HL. Tankou SK, et al. Mult Scler. 2018 Jan;24(1):58-63. doi: 10.1177/1352458517737390. Mult Scler. 2018. PMID: 29307299 Clinical Trial.
None of the disease-modifying therapies (DMTs) currently being used for the management of multiple sclerosis (MS) are 100% effective. In addition, side effects associated with the use of these DMTs have limited the practice of combination therapy. ...VSL3 administra …
None of the disease-modifying therapies (DMTs) currently being used for the management of multiple sclerosis (MS) are 100% eff …
Gut dysbiosis in autoimmune diseases: Association with mortality.
Chang SH, Choi Y. Chang SH, et al. Front Cell Infect Microbiol. 2023 Mar 31;13:1157918. doi: 10.3389/fcimb.2023.1157918. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37065187 Free PMC article. Review.
To better understand the impact of gut dysbiosis on four autoimmune diseases [Sjogren's syndrome (SS), systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and multiple sclerosis (MS)], this review investigated the altered gut bacteria in each disease and …
To better understand the impact of gut dysbiosis on four autoimmune diseases [Sjogren's syndrome (SS), systemic lupus erythematosus (SLE), r …
Investigating the metabolite signature of an altered oral microbiota as a discriminant factor for multiple sclerosis: a pilot study.
Boussamet L, Montassier E, Mathé C, Garcia A, Morille J, Shah S, Dugast E, Wiertlewski S, Gourdel M, Bang C, Stürner KH, Masson D, Nicot AB, Vince N, Laplaud DA, Feinstein DL, Berthelot L. Boussamet L, et al. Sci Rep. 2024 Apr 2;14(1):7786. doi: 10.1038/s41598-024-57949-4. Sci Rep. 2024. PMID: 38565581 Free PMC article.
In multiple sclerosis (MS), alterations of the gut microbiota lead to inflammation. However, the role of other microbiomes in the body in MS has not been fully elucidated. ...Our analysis revealed decreases in diversity indices and oral/faecal compartmentalization, …
In multiple sclerosis (MS), alterations of the gut microbiota lead to inflammation. However, the role of other microbiomes in …
The hidden link: How oral and respiratory microbiomes affect multiple sclerosis.
Jameie M, Ahli B, Ghadir S, Azami M, Amanollahi M, Ebadi R, Rafati A, Naser Moghadasi A. Jameie M, et al. Mult Scler Relat Disord. 2024 Aug;88:105742. doi: 10.1016/j.msard.2024.105742. Epub 2024 Jun 21. Mult Scler Relat Disord. 2024. PMID: 38964239 Review.
BACKGROUND: Extensive research has explored the role of gut microbiota in multiple sclerosis (MS). However, the impact of microbial communities in the oral cavity and respiratory tract on MS is an emerging area of investigation. ...Additionally, the presence of spec …
BACKGROUND: Extensive research has explored the role of gut microbiota in multiple sclerosis (MS). However, the impact of micr …
The Gut Microbiota in Multiple Sclerosis: An Overview of Clinical Trials.
Schepici G, Silvestro S, Bramanti P, Mazzon E. Schepici G, et al. Cell Transplant. 2019 Dec;28(12):1507-1527. doi: 10.1177/0963689719873890. Epub 2019 Sep 12. Cell Transplant. 2019. PMID: 31512505 Free PMC article.
Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating, and degenerative disease that affects the central nervous system. ...Studies report that patients with RR-MS have a microbiota that, compared with healthy controls, has higher amounts of Pedobacteria …
Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating, and degenerative disease that affects the central nervous s …
Gut Microbiota Changes during Dimethyl Fumarate Treatment in Patients with Multiple Sclerosis.
Ferri C, Castellazzi M, Merli N, Laudisi M, Baldin E, Baldi E, Mancabelli L, Ventura M, Pugliatti M. Ferri C, et al. Int J Mol Sci. 2023 Feb 1;24(3):2720. doi: 10.3390/ijms24032720. Int J Mol Sci. 2023. PMID: 36769041 Free PMC article.
The gut microbiota is involved in the development of the immune system and can modulate the risk for immune-mediated disorders such as multiple sclerosis (MS). Dysbiosis has been demonstrated in MS patients and its restoration by disease-modifying treatments (DMTs) …
The gut microbiota is involved in the development of the immune system and can modulate the risk for immune-mediated disorders such as mu …
CD46: the 'multitasker' of complement proteins.
Yamamoto H, Fara AF, Dasgupta P, Kemper C. Yamamoto H, et al. Int J Biochem Cell Biol. 2013 Dec;45(12):2808-20. doi: 10.1016/j.biocel.2013.09.016. Epub 2013 Oct 9. Int J Biochem Cell Biol. 2013. PMID: 24120647 Review.
53 results